GNMA 10: Policy and public affairs for life science companies

Strategic policy and public affairs activity can shape the environment for your company or product. It will address potential challenges or developments that may have an impact on patient access and make a case to government and policymakers across the UK and Europe on the most critical issues facing life science companies. It is particularly important for small and mid-sized life sciences companies to engage to ensure their voices are heard. A deep understanding of the policy and public affairs environment combined with established relationships with stakeholders and decision-makers ensures opportunities are created and optimised, threats mitigated and minimised and patient access to innovative technologies is accelerated.

This content is restricted to members. To view this content please register or login below to view this content.

Sign-Up For Free

Sign-up to receive up-to-date information and advice on tax developments within your industry.

Sign-up for free